412 filings
Page 4 of 21
DEFC14A
qhv35vq 6i
15 Mar 23
Proxy in contested solicitation
7:03am
8-K
hcb8dxbb ham
13 Mar 23
Regulation FD Disclosure
6:25am
UPLOAD
xts3v6
10 Mar 23
Letter from SEC
12:00am
S-8
4h7olukyzp
7 Mar 23
Registration of securities for employees
5:29pm
S-8
frcs1u3
7 Mar 23
Registration of securities for employees
5:28pm
DEFA14A
04mwwrzave0n
7 Mar 23
Additional proxy soliciting materials
4:42pm
8-K
yuvnzjq6t9rnqj5p9 ju
7 Mar 23
Zevra Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate Updates
8:20am
PRER14A
r1ia4
6 Mar 23
Preliminary revised proxy
4:39pm
CORRESP
r17qwy5lpdtixtl4
6 Mar 23
Correspondence with SEC
12:00am
DFAN14A
fobe0
3 Mar 23
Additional proxy materials by non-management
5:11pm
PREN14A
lhcxybwmpmpt81
3 Mar 23
Preliminary proxy statement filed by non-management
3:11pm
UPLOAD
di3i9 i9wew
3 Mar 23
Letter from SEC
12:00am
DEFA14A
y0syal6ve98nijgbi
27 Feb 23
Additional proxy soliciting materials
4:53pm
8-K
00ax16uq diaf4ft2
27 Feb 23
Regulation FD Disclosure
4:47pm
PREC14A
z1wagzyw gk5nulf5gd
27 Feb 23
Preliminary proxy with contested solicitation
4:10pm
8-K
95qwx
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
9:29pm
8-K
qm4tb
24 Jan 23
KemPharm Issues Letter to Shareholders
8:24pm
8-K
4j6cqu0l9inu
20 Jan 23
Other Events
5:05pm